HomePortfoliosVersion 1

Version 1

Version 1

Created byuser-5vfnu3
None Rebalancing
EUR
Moderate Risk
1.3yr backtest

Performance Summary

Total Return+11.52%
Annualized Return+8.73%
Volatility+15.92%
Sharpe Ratio0.42
Max Drawdown+21.32%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
EUR portfolio with diversified global ETFs for long-term growth. A simple, hands-off investment strategy with no rebalancing required.
AssetTypeAllocationTER
AVWS.XETRA
Avantis Global Small Cap Value UCITS ETF USD Acc • IE0003R87OG3
ETF
40.0%0.39%
SPYL.XETRA
State Street SPDR S&P 500 UCITS ETF USD Unhedged (Acc) • IE000XZSV718
ETF
30.0%0.03%
AVEM.XETRA
Avantis Emerging Markets Equity UCITS ETF USD Acc • IE000K975W13
ETF
20.0%0.35%
EXUS.XETRA
Xtrackers MSCI World ex USA UCITS ETF 1C • IE0006WW1TQ4
ETF
10.0%0.15%
Total100.0%0.25%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €11,152.43
Histogram of Monthly Returns
The portfolio had a positive return during 12 of the 17 months (71%)
Monthly Returns Heatmap
Best month: +6.7% • Worst month: -6.1% • Best year: 2025 (+10.6%) • Worst year: 2024 (-3.2%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+3.6%+3.9%-5.0%+1.8%--------+4.1%
2025+4.0%-2.3%-6.1%-5.0%+6.7%+1.0%+3.9%+1.9%+2.0%+3.0%+0.9%+1.0%+10.6%
2024------------3.2%-3.2%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +21.32% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -21.3%.

Detailed Metrics

Returns
Total Return
+11.52%
Annualized Return
+8.73%
Avg Monthly Return
+0.71%
Risk
Volatility (Annual)
+15.92%
Max Drawdown
+21.32%
Positive Months
71%
Average Drawdown
-4.2%
Risk-Adjusted
Sharpe Ratio
0.42
Risk-free rate: 2.0%
Sortino Ratio
0.38
Downside risk adjusted
Return/Volatility
0.55
Calmar Ratio
0.41
Return/Max Drawdown
Ulcer Index
5.65
Drawdown depth & duration
Martin Ratio
0.01
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€11,152.43
Backtest Period
2024-12-12 to 2026-04-02
1.3 years
Rebalancing
none
Base Currency
EUR